Advertisement

Topics

Roche gets rights to Go Therapeutics’ bispecific antibody

15:40 EDT 12 Oct 2018 | Elsevier Business Intelligence

GO Therapeutics Inc. licensed Roche exclusive global development and commercialization rights to a preclinical glycotargeting...

Original Article: Roche gets rights to Go Therapeutics’ bispecific antibody

NEXT ARTICLE

More From BioPortfolio on "Roche gets rights to Go Therapeutics’ bispecific antibody"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...